Acute Start (n = 57) | Chronic Start (n = 349) | P | |
---|---|---|---|
Age at dialysis start, years, (mean ± SD) | 71 ± 12.0 | 62 ± 16 | <0.001 |
Male gender, n (%) | 32 (57) | 202 (58) | 0.89 |
Caucasian race, n (%) | 50 (88) | 323 (93) | 0.20 |
Dialysis Access, n (%) | |||
CVC | 56 (98) | 182 (52) | <0.001 |
AVF | 1 (2) | 95 (27) | <0.001 |
PD catheter | 0 | 72 (21) | <0.001 |
Cause of ESRD, n (%) | |||
Diabetes | 8 (14) | 110 (32) | 0.007 |
Polycystic kidney disease | 2 (4) | 30 (9) | 0.29 |
Glomerulonephritis | 10 (18) | 44 (13) | 0.53 |
Referral time before dialysis start, days, (median, IQR) | 3, 1 to 33 | 1087, 443 to 2571 | <0.001 |
Referral < 3 months, n (%) | 47 (82) | 34 (10) | <0.001 |
Comorbidity | |||
CCI (median, IQR) | 5, 3 to 7 | 4, 2 to 6 | 0.03 |
Diabetes, n (%) | 23 (41) | 154 (44) | 0.38 |
Coronary artery disease, n (%) | 15 (27) | 100 (29) | 0.73 |
Congestive heart failure, n (%) | 17 (30) | 77 (22) | 0.18 |
Peripheral vascular disease n (%) | 14 (25) | 78 (22) | 0.73 |
Malignancya, n (%) | 17 (30) | 34 (10) | <0.001 |
Laboratory Values | |||
Hemoglobin, g/L, (mean ± SD) | 93 ± 15 | 100 ± 17 | 0.004 |
Albumin, g/L, (median, IQR) | 26, 23 to 30 | 33, 28 to 36 | <0.001 |
Phosphate, mmol/L, (median, IQR) | 1.9, 1.4 to 2.6 | 1.8, 1.5 to 2.2 | 0.33 |
Imputed phosphateb | 1.9, 1.5 to 2.6 | 1.9, 1.5 to 2.6 | 0.26 |
eGFR, ml/min/1.73 m2, (median, IQR) | 6.8, 5.0 to 9.0 | 7.8, 6.0 to 10 | 0.01 |
Imputed eGFRc | 6.8, 5.0 to 9.0 | 7.8, 6.0 to 10 | 0.01 |